Abstract:BACKGROUND: S100B is involved in brain injury. This study aimed to determine plasma and cerebral spinal fluid (CSF) levels of S100B in patients with spontaneous intracerebral hemorrhage (ICH), and to correlate S100B levels with Glasgow Coma Scale (GCS) scores, ICH volumes, presence of intraventricular hemorrhage (IVH), and survival rate, and to correlate CSF S100B levels with plasma S100B levels as well as CSF interleukin-1beta (IL-1 beta) levels.METHODS: Ten patients with suspicion of subarachnoid hemorrhage and 38 patients with spontaneous basal ganglia hemorrhage were included in the study. Their plasma and CSF samples were collected. The concentrations of IL-1 beta in CSF and S100B in plasma and CSF were analyzed by enzyme-linked immunosorbent assay.RESULTS: Plasma or CSF S100B levels in the ICH group were significantly higher than those in the control group (178.7 +/- 74.2 versus 63.2 +/- 23.0 pg/ml; P<0.001 or 158.1 +/- 70.9 versus 1.8 +/- 0.7 ng/ml; P<0.001). S100B levels were highly associated with GCS scores, ICH volumes, presence of IVH, and survival rate ( all P<0.05). CSF S100B levels were highly associated with plasma S100B levels as well as CSF IL-1 beta levels (both P<0.01) in patients with ICH. A receiver operating characteristic curve identified CSF and plasma S100B cutoff levels that predicted 1-week mortality of patients with a high sensitivity and specificity. The areas under curves (AUCs) of GCS scores and ICH volumes were larger than those of CSF and plasma S100B levels, but the differences were not statistically significant (P>0.05).CONCLUSION: High levels of S100B are present in the cerebrospinal fluid and peripheral blood of patients with ICH and may contribute to the inflammatory processes of ICH. The levels of CSF and plasma S100B after spontaneous onset of ICH seem to correlate with clinical outcome in these patients. Increases in peripheral S100B properly reflect brain injury, and plasma S100B level may serve as a useful clinical marker for evaluating the prognosis of ICH.

Immunohistochemical distribution of S-100 protein in the cerebral cortex with regard to the cause of death in forensic autopsy.

Postmortem Serum Protein S100B Levels with Regard to the Cause of Death Involving Brain Damage in Medicolegal Autopsy Cases.

Evaluation of Postmortem S100B Levels in the Cerebrospinal Fluid with Regard to the Cause of Death in Medicolegal Autopsy.

High S100B Levels in Cerebrospinal Fluid and Peripheral Blood of Patients with Acute Basal Ganglial Hemorrhage Are Associated with Poor Outcome.

Expression of RIPK-1 and S-100B in traumatic brain injury– exploring a forensic cases series

Single-stranded DNA as an immunohistochemical marker of neuronal damage in human brain: An analysis of autopsy material with regard to the cause of death

Morphological analysis of astrocytes in the hippocampus in mechanical asphyxiation

Analyses of Cardiac Blood Cells and Serum Proteins with Regard to Cause of Death in Forensic Autopsy Cases

Immunohistochemical Distribution of Basic Fibroblast Growth Factor (bfgf) in Medicolegal Autopsy

Post-mortem utility of Neuron Specific Enolase (NSE) and Calcium Binding Protein B (S100B) for differentiating traumatic brain injury from other causes of death

The Role of S100b Protein Biomarker in Brain Death: A Literature Review

Forensic pathological investigation of myocardial hypoxia-inducible factor-1α, erythropoietin and vascular endothelial growth factor in cardiac death

[Immunohistochemical Distribution of Single-Stranded DNA in the Brain in Medico-Legal Autopsy Cases of Carbon Monoxide Intoxication].

[Time-Dependent Expression of Astroglial S100beta Following Diffuse Brain Injury in Rats].

S100 Protein and Brain Injury Induced by Extracorporeal Circulation

Immunohistochemical Distribution of Chromogranin A in Medicolegal Autopsy Materials

Increased Serum S100B Concentration Correlates with Hippocampal S100B Overexpression and Cellular Damage Following Chronic Cerebral Hypoperfusion

Immunohistochemistry of Pulmonary Surfactant Apoprotein A in Forensic Autopsy: Reassessment in Relation to the Causes of Death

Postmortem Serum Levels of Pulmonary Surfactant-Associated Proteins A and D with Regard to the Cause of Death in Medicolegal Autopsy

The quantitative analysis of S100 in the brain tissue and serum following diffusebrain injury in rats

Quantitative analysis of single-stranded DNA immunoreactivity as a marker of neuronal apoptosis in hippocampus with regard to the causes of death in medicolegal autopsy